BNP Paribas Financial Markets
CSCI

BNP Paribas Financial Markets’s COSCIENS Biopharma Inc. Common Stock CSCI Stock Holding History

BNP Paribas Financial Markets’s Portfolio CSCI Stock Details CSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$339 – 5819
2025
Q2 		$339 Hold
100
– – ﹤0.01% 5253
2025
Q1 		$291 Hold
100
– – ﹤0.01% 5182
2024
Q4 		$271 Buy
+100
New +$326 ﹤0.01% 5217

Other funds holding CSCI

TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BNP Paribas Financial Markets's CSCI Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of COSCIENS Biopharma Inc. Common Stock (CSCI) in Q3 2025, closing a stake of 100 shares — an estimated $339 sold.

BNP Paribas Financial Markets first reported a position in CSCI in Q4 2024 and held it in 3 quarters. The position peaked at $339 in Q2 2025. 2 funds tracked by Wall St. Rank hold CSCI as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining COSCIENS Biopharma Inc. Common Stock position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 100 COSCIENS Biopharma Inc. Common Stock shares in Q3 2025, an estimated $339.
  • BNP Paribas Financial Markets first reported a position in COSCIENS Biopharma Inc. Common Stock in Q4 2024 and held it in 3 quarters.
  • BNP Paribas Financial Markets's COSCIENS Biopharma Inc. Common Stock position peaked at $339 in Q2 2025.
  • 2 funds tracked by Wall St. Rank held COSCIENS Biopharma Inc. Common Stock as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.